Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a class of drugs that have been gaining more attention in recent years for their efficacy and safety in treating type 2 diabetes mellitus (T2DM) (Nauck et al., 2021). The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.